Skip to main content
Clinical Trials/IRCT2014071918533N1
IRCT2014071918533N1
Completed
N/A

Comparison of efficacy of Botulinium Toxin A plus Triamcinolone intralesional injection with intralesional injection of Triamcinolone alone for treatment of keloid

euronox company(Tehran reseller)0 sites20 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
keloid scar.
Sponsor
euronox company(Tehran reseller)
Enrollment
20
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
euronox company(Tehran reseller)

Eligibility Criteria

Inclusion Criteria

  • ]nclusion criteria:patients should have at least too keloids on the skin ;age between 15 and 45 years
  • Exclusion criteria:pregnant or breast feeding women ;neuromuscular jaunction diseases or receiving neuromuscular junction blocker agents

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials